Takeshi Yamamoto Selected Research

Body Weight (Weight, Body)

8/2022	Effect of oral administration of a single bolus of six different protein sources on digestive physiology of red seabream Pagrus major juveniles.
8/2021	Effect of Empagliflozin Versus Placebo on Plasma Volume Status in Patients with Acute Myocardial Infarction and Type 2 Diabetes Mellitus.
10/2020	Metabolic effects of RUBCN/Rubicon deficiency in kidney proximal tubular epithelial cells.
1/2020	Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial.
2/2019	Effect of Dulaglutide Versus Liraglutide on Glucose Variability, Oxidative Stress, and Endothelial Function in Type 2 Diabetes: A Prospective Study.
6/2018	Comparison of liraglutide plus basal insulin and basal-bolus insulin therapy (BBIT) for glycemic control, body weight stability, and treatment satisfaction in patients treated using BBIT for type 2 diabetes without severe insulin deficiency: A randomized prospective pilot study.
11/2017	Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.
1/2017	Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.
1/2016	Glutamate promotes nucleotide synthesis in the gut and improves availability of soybean meal feed in rainbow trout.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takeshi Yamamoto Research Topics

Disease

38	Heart Failure 07/2023 - 02/2004
21	Myocardial Infarction 02/2023 - 06/2004
19	Type 2 Diabetes Mellitus (MODY) 10/2023 - 07/2006
18	Food Hypersensitivity (Food Allergy) 01/2023 - 06/2007
14	Cardiac Arrhythmias (Arrythmia) 01/2023 - 09/2005
13	Ventricular Tachycardia 01/2023 - 06/2005
10	ST Elevation Myocardial Infarction 01/2023 - 04/2006
10	Polymorphic catecholergic ventricular tachycardia 01/2019 - 09/2005
9	Body Weight (Weight, Body) 08/2022 - 01/2016
8	Hemorrhage 06/2023 - 10/2003
8	Thrombosis (Thrombus) 02/2023 - 02/2011
8	Acute Coronary Syndrome 01/2023 - 07/2005
8	Aortic Dissection 01/2023 - 04/2005
8	Inflammation (Inflammations) 01/2023 - 09/2007
8	Malignant Hyperthermia 10/2022 - 01/2002
8	Colitis 01/2022 - 01/2010
8	Pulmonary Embolism 12/2015 - 10/2003
7	Shock 08/2022 - 06/2004
6	Cardiogenic Shock 12/2023 - 10/2003
6	Hypertension (High Blood Pressure) 07/2023 - 09/2007
6	Diarrhea 01/2023 - 03/2002
6	Infections 04/2020 - 05/2010
5	Neoplasms (Cancer) 12/2021 - 11/2009
5	Fibrosis (Cirrhosis) 01/2021 - 09/2006
4	Out-of-Hospital Cardiac Arrest 03/2024 - 04/2008
4	Hypertrophy 01/2023 - 12/2018
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2016
4	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 05/2020 - 06/2004
4	Starvation 01/2019 - 01/2016
4	Pulmonary Edema 09/2014 - 01/2006
3	Hypertriglyceridemia 12/2023 - 06/2007
3	Takotsubo Cardiomyopathy 11/2023 - 01/2018
3	Obesity 09/2023 - 09/2007
3	Cardiomegaly (Heart Hypertrophy) 07/2023 - 12/2018
3	Unstable Angina 01/2023 - 07/2005
3	Ventricular Remodeling 01/2023 - 01/2023
3	Heart Arrest (Cardiac Arrest) 08/2022 - 10/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 09/2007
3	Rectal Neoplasms (Rectal Cancer) 06/2022 - 12/2021
3	Proteinuria 12/2021 - 01/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 09/2007
3	Ischemia 10/2020 - 01/2012
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 01/2018
3	Immune System Diseases (Immune Disorders) 01/2020 - 01/2014
3	Ventricular Fibrillation 12/2019 - 06/2004
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 08/2008
3	Heart Diseases (Heart Disease) 10/2017 - 03/2002

Drug/Important Bio-Agent (IBA)

36	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2023 - 01/2002
13	Dantrolene (Dantrium)FDA LinkGeneric 01/2023 - 09/2002
12	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2023 - 04/2010
10	Proteins (Proteins, Gene)FDA Link 08/2022 - 09/2005
7	LDL CholesterolIBA 12/2023 - 06/2007
7	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 12/2016
6	Biomarkers (Surrogate Marker)IBA 12/2021 - 09/2007
5	empagliflozinIBA 01/2022 - 10/2018
5	Dextran SulfateIBA 09/2021 - 11/2014
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2016
5	Adenosine Triphosphate (ATP)IBA 01/2021 - 11/2008
5	kakkon-toIBA 01/2020 - 01/2009
5	Messenger RNA (mRNA)IBA 01/2020 - 01/2013
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023 - 06/2007
4	Cholinergic Agents (Cholinergics)IBA 01/2023 - 11/2008
4	SolutionsIBA 01/2022 - 03/2002
4	CatecholaminesIBA 01/2022 - 01/2016
4	CytokinesIBA 01/2022 - 01/2006
4	Therapeutic UsesIBA 01/2022 - 01/2009
4	Sodium-Glucose Transport ProteinsIBA 01/2022 - 10/2018
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 07/2006
4	AntigensIBA 01/2021 - 04/2008
4	Insulin (Novolin)FDA Link 10/2020 - 07/2006
4	Amino Acids FDA Link 01/2020 - 11/2010
4	EnzymesIBA 01/2020 - 09/2006
4	Epinephrine (Adrenaline)FDA LinkGeneric 01/2020 - 11/2010
4	CreatinineIBA 10/2019 - 08/2006
4	oxidized low density lipoproteinIBA 11/2017 - 07/2006
4	CalciumIBA 12/2012 - 11/2008
4	Peptides (Polypeptides)IBA 09/2005 - 01/2002
3	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 07/2008
3	Green Fluorescent ProteinsIBA 07/2022 - 01/2016
3	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 01/2008
3	Nicotine FDA Link 01/2022 - 01/2014
3	OxazoloneIBA 01/2022 - 01/2010
3	Drinking WaterIBA 09/2021 - 01/2017
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 10/2017
3	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2019
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 04/2017
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021 - 01/2016
3	Glucagon (Glukagon)FDA Link 12/2019 - 01/2013
3	Liraglutide FDA Link 02/2019 - 12/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2019 - 08/2006
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2018 - 10/2003

Therapy/Procedure

34	Therapeutics 02/2024 - 03/2002
9	Percutaneous Coronary Intervention 02/2023 - 06/2006
8	Catheters 01/2023 - 10/2003
7	Thrombectomy 02/2023 - 05/2004
5	Cardiopulmonary Resuscitation (CPR) 03/2024 - 09/2014
5	Extracorporeal Membrane Oxygenation 12/2023 - 01/2006
5	Drug Therapy (Chemotherapy) 07/2023 - 01/2012
4	Stents 01/2023 - 01/2012
3	Mechanical Ventilators (Ventilator) 09/2021 - 01/2009